Psychedelics and Psychedelic-Assisted Psychotherapy

灵霉素 致幻剂 阿亚瓦斯卡 MDMA公司 麦角酸二乙酰胺 焦虑 精神科 心理学 心情 临床试验 临床心理学 医学 内科学 受体 血清素 社会学 人类学
作者
Collin Reiff,Elon E. Richman,Charles B. Nemeroff,Linda L. Carpenter,Alik S. Widge,Carolyn I. Rodríguez,Ned H. Kalin,William M. McDonald
出处
期刊:American Journal of Psychiatry [American Psychiatric Association Publishing]
卷期号:177 (5): 391-410 被引量:421
标识
DOI:10.1176/appi.ajp.2019.19010035
摘要

The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.Searches of PubMed and PsycINFO via Ovid were conducted for articles in English, in peer-reviewed journals, reporting on "psilocybin," "lysergic acid diethylamide," "LSD," "ayahuasca," "3,4-methylenedioxymethamphetamine," and "MDMA," in human subjects, published between 2007 and July 1, 2019. A total of 1,603 articles were identified and screened. Articles that did not contain the terms "clinical trial," "therapy," or "imaging" in the title or abstract were filtered out. The 161 remaining articles were reviewed by two or more authors. The authors identified 14 articles reporting on well-designed clinical trials investigating the efficacy of lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and ayahuasca for the treatment of mood and anxiety disorders, trauma and stress-related disorders, and substance-related and addictive disorders as well as in end-of-life care.The most significant database exists for MDMA and psilocybin, which have been designated by the U.S. Food and Drug Administration (FDA) as "breakthrough therapies" for posttraumatic stress disorder (PTSD) and treatment-resistant depression, respectively. The research on LSD and ayahuasca is observational, but available evidence suggests that these agents may have therapeutic effects in specific psychiatric disorders.Randomized clinical trials support the efficacy of MDMA in the treatment of PTSD and psilocybin in the treatment of depression and cancer-related anxiety. The research to support the use of LSD and ayahuasca in the treatment of psychiatric disorders is preliminary, although promising. Overall, the database is insufficient for FDA approval of any psychedelic compound for routine clinical use in psychiatric disorders at this time, but continued research on the efficacy of psychedelics for the treatment of psychiatric disorders is warranted.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
rainsy发布了新的文献求助10
1秒前
解忧的地坛完成签到,获得积分10
2秒前
2秒前
2秒前
sui发布了新的文献求助10
2秒前
张兰兰发布了新的文献求助10
2秒前
3秒前
量子星尘发布了新的文献求助10
3秒前
星苒完成签到,获得积分20
4秒前
4秒前
江静歌完成签到,获得积分10
4秒前
慕青应助蟹黄味采纳,获得10
4秒前
5秒前
大力出奇迹完成签到,获得积分10
5秒前
王长莲发布了新的文献求助10
5秒前
周芷卉发布了新的文献求助10
5秒前
丢丢银完成签到,获得积分10
6秒前
6秒前
啦啦啦完成签到,获得积分10
6秒前
6秒前
小伙伴完成签到,获得积分10
6秒前
香蕉觅云应助满意的蜗牛采纳,获得10
7秒前
7秒前
7秒前
咕噜咕噜发布了新的文献求助10
7秒前
852应助rainsy采纳,获得10
7秒前
7秒前
8秒前
8秒前
XiaohuLee发布了新的文献求助10
8秒前
ATM发布了新的文献求助10
9秒前
kk发布了新的文献求助10
9秒前
浅忆完成签到,获得积分10
9秒前
wwlllzzttt关注了科研通微信公众号
10秒前
大方煎蛋完成签到,获得积分20
10秒前
ifast完成签到 ,获得积分10
10秒前
Ce发布了新的文献求助10
11秒前
大力雅柏完成签到,获得积分10
11秒前
无语的大门完成签到,获得积分10
11秒前
小蘑菇应助千与千夜采纳,获得10
11秒前
高分求助中
2025-2031全球及中国金刚石触媒粉行业研究及十五五规划分析报告 40000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Agyptische Geschichte der 21.30. Dynastie 3000
Les Mantodea de guyane 2000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
„Semitische Wissenschaften“? 1510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5749029
求助须知:如何正确求助?哪些是违规求助? 5456131
关于积分的说明 15362419
捐赠科研通 4888546
什么是DOI,文献DOI怎么找? 2628508
邀请新用户注册赠送积分活动 1576865
关于科研通互助平台的介绍 1533626